Chorioangioma: Causes and Treatments
Chorioangioma is a rare vascular tumour of the placenta that can have significant implications for pregnancy outcomes. Although often benign, its presence can lead to complications that necessitate careful monitoring and management.
They are the most common type of placental tumour, yet they are still relatively rare, occurring in approximately 1% of pregnancies. The tumours are made up of blood vessels and connective tissue and can vary significantly in size. Small chorioangiomas often remain asymptomatic and are incidentally discovered during routine ultrasounds. Larger tumours, however, can lead to complications such as fetal anaemia, polyhydramnios, and preterm birth.
Causes of Chorioangioma
Genetic and Environmental Factors
While the exact aetiology of chorioangioma remains unclear, several genetic and environmental factors may contribute to its development. Research suggests that genetic abnormalities in the placental tissue could predispose individuals to chorioangioma formation. Environmental factors, such as maternal smoking or exposure to certain chemicals, have also been implicated, although evidence is less conclusive.
Hormonal Influences
Hormonal changes during pregnancy might play a role in the development of chorioangiomas. Elevated levels of certain hormones could potentially stimulate the proliferation of vascular tissue within the placenta, contributing to tumour growth.
Secure your health with a second opinion. Make informed decisions and book your appointment today!
Get A Second OpinionTypes of Chorioangioma
Chorioangiomas can be classified based on their size and potential impact on the pregnancy.
Small Chorioangiomas
These are typically less than 5 cm in diameter and asymptomatic. They are often discovered incidentally during routine prenatal ultrasounds and do not typically require intervention.
Large Chorioangiomas
Tumors larger than 5 cm are considered significant and may lead to complications. These tumours require close monitoring and, in some cases, intervention to manage associated risks.
Giant Chorioangiomas
Giant chorioangiomas exceed 10 cm in diameter and are associated with significant complications, including fetal growth restriction, hydrops fetalis, and even intrauterine fetal demise. These cases often necessitate multidisciplinary management.
Symptoms and Diagnosis of Chorioangioma
Common Symptoms
The symptoms of chorioangioma depend largely on the size of the tumour. Smaller chorioangiomas are usually asymptomatic, while larger ones may present with:
- Polyhydramnios (excessive amniotic fluid)
- Fetal anemia
- Maternal mirror syndrome (a condition resembling preeclampsia)
- Preterm labour
Diagnosis
Chorioangiomas are typically diagnosed through prenatal ultrasound, where they appear as well-circumscribed, hypoechoic lesions within the placenta. Color Doppler imaging can further aid in diagnosis by highlighting the tumour's vascular nature. In some cases, MRI may be used to assess the extent of very large tumours.
Chorioangioma Prognosis
The prognosis of chorioangioma largely depends on the size and impact of the tumour. Small, asymptomatic chorioangiomas generally have an excellent prognosis and do not affect pregnancy outcomes. Larger tumours, however, can pose significant risks to both the mother and the fetus, necessitating careful monitoring and management throughout the pregnancy.
Ready to take control of your health journey? Book your appointment now and start your path towards wellness today!
Book an AppointmentTreatment and Management of Chorioangioma
The management of chorioangioma depends on the size of the tumour and the presence of any complications.
Observation and Monitoring
For small, asymptomatic chorioangiomas, regular ultrasound monitoring is typically sufficient. This allows healthcare providers to track the tumour's growth and any potential impact on the fetus.
Interventional Procedures
In cases where the tumour is large and causing complications, interventional procedures may be necessary. These can include:
- Amnioreduction: Reducing excess amniotic fluid to manage polyhydramnios.
- Intrauterine transfusions: Administering blood transfusions to the fetus in cases of severe anemia.
- Laser ablation: Laser therapy is used to reduce blood flow to the tumour and mitigate its effects.
Delivery Planning
The timing and mode of delivery may be influenced by the presence of a large chorioangioma. In some cases, early delivery may be warranted to prevent further complications. The mode of delivery will depend on the tumour's size, location, and effect on the placental function.
Chorioangioma Management During Pregnancy
Multidisciplinary Approach
Effective management of chorioangioma often requires a multidisciplinary approach involving obstetricians, neonatologists, and pediatric specialists. This team-based approach ensures comprehensive care and optimal outcomes for both the mother and the fetus.
Patient Education and Support
Educating patients about the condition, its potential complications, and the management strategies is crucial. Providing emotional support and counselling can help patients cope with the stress and uncertainty associated with a chorioangioma diagnosis.
Frequently Asked Questions
1. What are the symptoms of chorioangioma?
Symptoms may include abnormal fetal growth, complications during pregnancy, or no noticeable symptoms, depending on the size and location of the tumor.
2. What causes chorioangioma?
Chorioangiomas are benign tumors of the placenta that develop from blood vessels, often linked to abnormal placental development during pregnancy.
3. How is chorioangioma diagnosed?
Diagnosis usually occurs through ultrasound imaging, allowing healthcare providers to monitor fetal development and placental health.
4. What treatments are available for chorioangioma?
Treatment may involve monitoring the condition and, in some cases, surgical intervention if complications arise during pregnancy.
5. What types of chorioangioma are there?
Types may vary based on size and blood flow characteristics, affecting management strategies during pregnancy.